Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein.
The ribosomal P proteins are located on the stalk of the ribosomal large subunit and play a critical role during the elongation step of protein synthesis. The single chain recombinant antibody C5 (scFv C5) directed against the C-terminal region of the Trypanosoma cruzi P2β protein (TcP2β) recognizes...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/868a09413ac44ebf9c52176ad53a898d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:868a09413ac44ebf9c52176ad53a898d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:868a09413ac44ebf9c52176ad53a898d2021-11-18T07:19:49ZSelective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein.1932-620310.1371/journal.pone.0036233https://doaj.org/article/868a09413ac44ebf9c52176ad53a898d2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22570698/?tool=EBIhttps://doaj.org/toc/1932-6203The ribosomal P proteins are located on the stalk of the ribosomal large subunit and play a critical role during the elongation step of protein synthesis. The single chain recombinant antibody C5 (scFv C5) directed against the C-terminal region of the Trypanosoma cruzi P2β protein (TcP2β) recognizes the conserved C-terminal end of all T. cruzi ribosomal P proteins. Although this region is highly conserved among different species, surface plasmon resonance analysis showed that the scFv C5 possesses very low affinity for the corresponding mammalian epitope, despite having only one single amino-acid change. Crystallographic analysis, in silico modelization and NMR assays support the analysis, increasing our understanding on the structural basis of epitope specificity. In vitro protein synthesis experiments showed that scFv C5 was able to specifically block translation by T. cruzi and Crithidia fasciculata ribosomes, but virtually had no effect on Rattus norvegicus ribosomes. Therefore, we used the scFv C5 coding sequence to make inducible intrabodies in Trypanosoma brucei. Transgenic parasites showed a strong decrease in their growth rate after induction. These results strengthen the importance of the P protein C terminal regions for ribosomal translation activity and suggest that trypanosomatid ribosomal P proteins could be a possible target for selective therapeutic agents that could be derived from structural analysis of the scFv C5 antibody paratope.Maximiliano Juri AyubBenson NyambegaLeandro SimonettiTomas DuffySilvia A LonghiKarina A GómezJohan HoebekeMariano J LevinCristian R SmulskiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 5, p e36233 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Maximiliano Juri Ayub Benson Nyambega Leandro Simonetti Tomas Duffy Silvia A Longhi Karina A Gómez Johan Hoebeke Mariano J Levin Cristian R Smulski Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein. |
description |
The ribosomal P proteins are located on the stalk of the ribosomal large subunit and play a critical role during the elongation step of protein synthesis. The single chain recombinant antibody C5 (scFv C5) directed against the C-terminal region of the Trypanosoma cruzi P2β protein (TcP2β) recognizes the conserved C-terminal end of all T. cruzi ribosomal P proteins. Although this region is highly conserved among different species, surface plasmon resonance analysis showed that the scFv C5 possesses very low affinity for the corresponding mammalian epitope, despite having only one single amino-acid change. Crystallographic analysis, in silico modelization and NMR assays support the analysis, increasing our understanding on the structural basis of epitope specificity. In vitro protein synthesis experiments showed that scFv C5 was able to specifically block translation by T. cruzi and Crithidia fasciculata ribosomes, but virtually had no effect on Rattus norvegicus ribosomes. Therefore, we used the scFv C5 coding sequence to make inducible intrabodies in Trypanosoma brucei. Transgenic parasites showed a strong decrease in their growth rate after induction. These results strengthen the importance of the P protein C terminal regions for ribosomal translation activity and suggest that trypanosomatid ribosomal P proteins could be a possible target for selective therapeutic agents that could be derived from structural analysis of the scFv C5 antibody paratope. |
format |
article |
author |
Maximiliano Juri Ayub Benson Nyambega Leandro Simonetti Tomas Duffy Silvia A Longhi Karina A Gómez Johan Hoebeke Mariano J Levin Cristian R Smulski |
author_facet |
Maximiliano Juri Ayub Benson Nyambega Leandro Simonetti Tomas Duffy Silvia A Longhi Karina A Gómez Johan Hoebeke Mariano J Levin Cristian R Smulski |
author_sort |
Maximiliano Juri Ayub |
title |
Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein. |
title_short |
Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein. |
title_full |
Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein. |
title_fullStr |
Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein. |
title_full_unstemmed |
Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein. |
title_sort |
selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-trypanosoma cruzi p2β protein. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/868a09413ac44ebf9c52176ad53a898d |
work_keys_str_mv |
AT maximilianojuriayub selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT bensonnyambega selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT leandrosimonetti selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT tomasduffy selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT silviaalonghi selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT karinaagomez selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT johanhoebeke selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT marianojlevin selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein AT cristianrsmulski selectiveblockadeoftrypanosomatidproteinsynthesisbyarecombinantantibodyantitrypanosomacruzip2bprotein |
_version_ |
1718423608694407168 |